Rigel Pharmaceuticals
RIGL
RIGL
118 hedge funds and large institutions have $163M invested in Rigel Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 39 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
14% less funds holding
Funds holding: 138 → 118 (-20)
61% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 33
Holders
118
Holding in Top 10
–
Calls
$1.02M
Puts
$25K
Top Buyers
| 1 | +$20.3M | |
| 2 | +$2.2M | |
| 3 | +$2.04M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.02M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$859K |
Top Sellers
| 1 | -$9.89M | |
| 2 | -$7.5M | |
| 3 | -$6.02M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.22M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$3.89M |